---
schema_version: "secwatch.filing_event.v1"
accession: "0001279569-25-000884"
form_type: "8-K"
ticker: "CWBHF"
cik: "0001750155"
company_name: "Charlotte's Web Holdings, Inc."
filed_at: "2025-08-13T23:59:59+00:00"
generated_at: "2026-05-17T13:57:57.340649+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Charlotte's Web Q2 revenue up 4.2% YoY to $12.8M; net loss narrows to $6.3M

## Summary
- Revenue $12.8M, +4.2% YoY; net loss $6.3M (-$0.04/share) vs $11.0M loss (-$0.07) in Q2 2024.
- Adjusted EBITDA improved 30.8% to -$3.6M; SG&A down 31.7% to $10.1M.
- In-house production of Brightside THC gummies expanded; expects ~$9M annualized cost savings by 2026.
- Cash $15.3M; working capital $29.4M; reduced cash burn 52% in H1 2025.
- DeFloria Phase 2 trials for ASD irritability underway; regulatory progress expected.

## SEC filing metadata
- accession: 0001279569-25-000884
- form_type: 8-K
- ticker: CWBHF
- cik: 0001750155
- company_name: Charlotte's Web Holdings, Inc.
- filed_at: 2025-08-13T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1750155/000127956925000884/0001279569-25-000884-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1750155/000127956925000884/charlotteform8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001279569-25-000884
- JSON: https://secwatch.observer/filing/0001279569-25-000884.json
- Plain text: https://secwatch.observer/filing/0001279569-25-000884.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.